» Articles » PMID: 15348781

Biomechanical Assessment of Bone Ingrowth in Porous Hydroxyapatite

Overview
Publisher Springer
Date 2004 Sep 7
PMID 15348781
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Porous hydroxyapatite (Endobon) specimens were implanted into the femoral condyle of New Zealand White rabbits for up to 6 months. After sacrifice, specimens were sectioned for histology and mechanical testing, where the extent of reinforcement by bony ingrowth was assessed by compression testing and fixation was assessed by push-out testing. From histological observations, it was established that the majority of bone ingrowth occurred between 10 day and 5 weeks after implantation and proceeded predominantly from the deep end of the trephined defect, with some integration from the circumferential sides. At 3 months, the implants were fully integrated, exhibiting bony ingrowth, vascularization and bone marrow stroma within the internal macropores. After 5 weeks, the mean ultimate compressive strength of retrieved implants (6.9 MPa) was found to be greater than that of the original implant (2.2 MPa), and by 3 months the fully integrated implants attained a compressive strength of approximately 20 MPa. Push-out testing demonstrated that after 5 weeks in vivo, the interfacial shear strength reached 3.2 MPa, increasing to 7.3 MPa at 3 and 6 months.

Citing Articles

Osteogenic capacity of nanocrystalline bone cement in a weight-bearing defect at the ovine tibial metaphysis.

Harms C, Helms K, Taschner T, Stratos I, Ignatius A, Gerber T Int J Nanomedicine. 2012; 7:2883-9.

PMID: 22745551 PMC: 3384364. DOI: 10.2147/IJN.S29314.


Biomechanical evaluation of porous bioactive ceramics after implantation: micro CT-based three-dimensional finite element analysis.

Ren L, Arahira T, Todo M, Yoshikawa H, Myoui A J Mater Sci Mater Med. 2011; 23(2):463-72.

PMID: 22109903 DOI: 10.1007/s10856-011-4469-2.


Clinical effects of nanocrystalline hydroxyapatite paste in the treatment of intrabony periodontal defects: a randomized controlled clinical study.

Heinz B, Kasaj A, Teich M, Jepsen S Clin Oral Investig. 2009; 14(5):525-31.

PMID: 19680697 DOI: 10.1007/s00784-009-0325-x.


Nanomechanical characterization of tissue engineered bone grown on titanium alloy in vitro.

Chen J, Birch M, Bull S J Mater Sci Mater Med. 2009; 21(1):277-82.

PMID: 19669624 DOI: 10.1007/s10856-009-3843-9.


Osseointegration in arthroplasty: can simvastatin promote bone response to implants?.

Basarir K, Erdemli B, Can A, Erdemli E, Zeyrek T Int Orthop. 2007; 33(3):855-9.

PMID: 18157535 PMC: 2903108. DOI: 10.1007/s00264-007-0490-y.


References
1.
Maxian S, Zawadsky J, Dunn M . Effect of Ca/P coating resorption and surgical fit on the bone/implant interface. J Biomed Mater Res. 1994; 28(11):1311-9. DOI: 10.1002/jbm.820281109. View

2.
Martin R, Chapman M, Sharkey N, Zissimos S, Bay B, Shors E . Bone ingrowth and mechanical properties of coralline hydroxyapatite 1 yr after implantation. Biomaterials. 1993; 14(5):341-8. DOI: 10.1016/0142-9612(93)90052-4. View

3.
Moroni A, Caja V, Egger E, TRINCHESE L, Chao E . Histomorphometry of hydroxyapatite coated and uncoated porous titanium bone implants. Biomaterials. 1994; 15(11):926-30. DOI: 10.1016/0142-9612(94)90119-8. View

4.
Renooij W, Hoogendoorn H, Visser W, Lentferink R, Schmitz M, Van Ieperen H . Bioresorption of ceramic strontium-85-labeled calcium phosphate implants in dog femora. A pilot study to quantitate bioresorption of ceramic implants of hydroxyapatite and tricalcium orthophosphate in vivo. Clin Orthop Relat Res. 1985; (197):272-85. View

5.
Rootare H, Craig R . Characterization of hydroxyapatite powders and compacts at room temperature and after sintering at 1200 degrees C. J Oral Rehabil. 1978; 5(3):293-307. DOI: 10.1111/j.1365-2842.1978.tb01247.x. View